Drug
Glembatumumab Vedotin
Glembatumumab Vedotin: highest development phase Phase 2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| glembatumumab vedotin NCT02302339 | Phase 2 | Melanoma |
Latest
No recent events.
Follow Glembatumumab Vedotin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.